Penserra Capital Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,765
| Closed | -$37K | – | 1593 |
|
|
2021
Q3 | $37K | Buy |
1,765
+10
| +0.6% | +$210 | ﹤0.01% | 1141 |
|
|
2021
Q2 | $34K | Buy |
1,755
+90
| +5% | +$1.74K | ﹤0.01% | 1079 |
|
|
2021
Q1 | $48K | Buy |
1,665
+80
| +5% | +$2.31K | ﹤0.01% | 820 |
|
|
2020
Q4 | $48K | Buy |
1,585
+997
| +170% | +$30.2K | ﹤0.01% | 695 |
|
|
2020
Q3 | $9K | Buy |
+588
| New | +$9K | ﹤0.01% | 829 |
|